Q3 2025 Krishna Institute of Medical Sciences Ltd Earnings Call Transcript
Key Points
- Krishna Institute of Medical Sciences Ltd (BOM:543308) reported a significant year-on-year revenue growth of 29.7%, reaching INR790 crores.
- EBITDA grew by 36.4% year-on-year, indicating strong operational performance.
- The company has successfully opened a 200-bed multi-specialty hospital at Guindy and signed an agreement with Valiyath Institute of Medical Sciences Hospital in Kerala, expanding its footprint.
- KIMS has set a benchmark in neurocare with South Asia's first MRI-guided focused ultrasound, enhancing its technological capabilities.
- The company is actively expanding its operations with new projects in Bangalore and Bombay, indicating future growth potential.
- Quarter-on-quarter revenue saw a slight decline of 0.6%, indicating potential short-term challenges.
- EBITDA margin declined by 8.1% quarter-on-quarter, reflecting some operational inefficiencies.
- The Maharashtra cluster experienced a sharp decline in margins due to seasonal impacts and one-off write-offs.
- Corporate overheads have increased, partly due to recruitment in various clusters, impacting profitability.
- There are delays in the execution of the second project in Bangalore, pushing the timeline to Q2 FY26.
Ladies and gentlemen, good day and welcome to the KIM's Hospitals Q3 FY25 earnings conference call hosted by IIFL Capital. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Rahul Jeevani from IIFL Capital. Thank you, and over to you, sir.
Hi, good morning, everyone. This is Rahul from IIFL. I welcome you all to the third-quarter earnings conference call of KIM's Hospitals being hosted by IIFL Capital. From KIM's, we have with us today Dr. Bhaskara Bollineni, Founder and Managing Director; Dr. Abhinaya Bollineni, Executive Director and CEO; Mr. Sachin Salvi, CFO; Dr. Nitish Shetty, CEO for KIM's Bangalore Cluster; and Mr. Srinath Reddy, Director, Business Strategy and M&A.
Over to you, sir, for your opening comments.
Good morning. I extend a warm welcome to all for the first investors' meet of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
